Letter from the Editor EditorDr Triana Lobatón, Ghent University Hospital, Belgium ConferenceECCO 2019 9 May, 2019 23:10
Interview with Prof. Janneke van der Woude ExpertProf. Janneke van der Woude, Erasmus University Medical Center, the Netherlands ConferenceECCO 2019 9 May, 2019 12:27
Selective oral sphingosine 1-phosphate receptor modulator amiselimod ConferenceECCO 2019 9 May, 2019 22:21
Selective sphingosine-1-phosphate receptor modulator etrasimod TrialPhase 2, OASIS ConferenceECCO 2019 9 May, 2019 20:24
Upadacitinib: data from U-ACHIEVE and CELEST TrialU-ACHIEVE and CELEST ConferenceECCO 2019 9 May, 2019 17:48
The right drug for the right patient Presented ByDr Charlie Lees, Western General Hospital, United Kingdom TrialPROFILE ConferenceECCO 2019 9 May, 2019 23:55
Vedolizumab superior to adalimumab in ulcerative colitis Presented ByDr Stefan Schreiber, University-Hospital Schleswig-Holstein, Germany TrialPhase 3, VARSITY ConferenceECCO 2019 9 May, 2019 22:57
Vedolizumab: Results from the GEMINI programme TrialPhase 3, GEMINI ConferenceECCO 2019 9 May, 2019 21:59
Ustekinumab as maintenance therapy and with shortened interval TrialPhase 3, UNIFI ConferenceECCO 2019 9 May, 2019 20:11
Tofacitinib: Results from the OCTAVE open-label studies TrialOCTAVE ConferenceECCO 2019 9 May, 2019 19:13
Limited long-term effectiveness and safety of tacrolimus in ulcerative colitis ConferenceECCO 2019 9 May, 2019 17:19
Topical review Presented ByDr Joana Torres & Prof. Stephan Vavricka ConferenceECCO 2019 9 May, 2019 23:51
Complementary and alternative medicine associated with chronic fatigue and lower QoL ConferenceECCO 2019 9 May, 2019 22:53
Crohn’s disease exclusion diet + partial enteral nutrition in paediatric Crohn’s disease Presented ByDr Arie Levine, Mount Saint Vincent University, Canada ConferenceECCO 2019 9 May, 2019 21:56
Microbial composition and psychological wellbeing Presented ByDr Luc Biedermann, University Hospital Zurich, Switzerland ConferenceECCO 2019 9 May, 2019 20:03
Glycans as novel immunomodulators in inflammatory bowel disease ConferenceECCO 2019 9 May, 2019 10:04
Early remission of Crohn’s disease prevents progression Presented ByDr Thierry Yzet, Amiens University Hospital, France TrialCALM ConferenceECCO 2019 9 May, 2019 20:08
Histological remission predicts relapse-free survival in ulcerative colitis ConferenceECCO 2019 9 May, 2019 19:10
Proactive adalimumab trough measurements Presented ByDr Amit Assa, Schneider Children’s Hospital, Israel ConferenceECCO 2019 9 May, 2019 10:20
The costs and benefits of biologicals Presented ByDr Johan Burisch, Frederiksberg Hospital, Denmark TrialCohort study, Epi-IBD ConferenceECCO 2019 9 May, 2019 20:34
Efficacy and safety of biosimilars TrialCONNECT-IBD and SPOSIB SB2 ConferenceECCO 2019 9 May, 2019 19:35
IBD risk of treatment with IL-17 antagonists Presented ByDr Wolfgang Eigner, Medical University of Vienna, Austria ConferenceECCO 2019 9 May, 2019 14:37
Immune cells and microbes: a happy marriage? Presented ByDr Loris Lopetuso, Catholic University of the Sacred Heart, Italy ConferenceECCO 2019 9 May, 2019 19:42
Novel host-microbiome interactions in inflammatory bowel disease ConferenceECCO 2019 9 May, 2019 20:46
Gene expression signature predicts non-response TrialACT1, PURSUIT-SC, PROgECT, PURSUIT-J, UNITI ConferenceECCO 2019 9 May, 2019 18:48